Robert W. Ross - Jun 15, 2022 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield , Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 04:08 PM
Previous filing
Mar 3, 2022
Next filing
Aug 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +26.4K $0.00 26.4K Jun 15, 2022 Common Stock 26.4K $2.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on June 15, 2022 and will vest in three equal installments on June 15, 2023, June 15, 2024 and June 15, 2025.